Authors:
Hennequin, C
Gayet, B
Sauvanet, A
Blazy, A
Perniceni, T
Panis, Y
Mal, F
Sarfati, E
Valleur, P
Belghiti, J
Fekete, F
Maylin, C
Citation: C. Hennequin et al., Impact on survival of surgery after concomitant chemoradiotherapy for locally advanced cancers of the esophagus, INT J RAD O, 49(3), 2001, pp. 657-664
Authors:
Cattan, P
Chiche, P
Berney, T
Halimi, B
Aidan, K
Celerier, M
Sarfati, E
Citation: P. Cattan et al., Surgical approach by cervicosternolaparotomy for the treatment of extendedcervical stenoses after reconstruction for caustic injury, J THOR SURG, 122(2), 2001, pp. 384-386
Authors:
Roussanne, MC
Lieberherr, M
Souberbielle, JC
Sarfati, E
Drueke, T
Bourdeau, A
Citation: Mc. Roussanne et al., Human parathyroid cell proliferation in response to calcium, NPS R-467, calcitriol and phosphate, EUR J CL IN, 31(7), 2001, pp. 610-616
Authors:
de Labriolle-Vaylet, C
Cattan, P
Sarfati, E
Wioland, M
Billotey, C
Brocheriou, C
Rouvier, E
de Roquancourt, A
Rostene, W
Askienazy, S
Barbet, J
Milhaud, G
Gruaz-Guyon, A
Citation: C. De Labriolle-vaylet et al., Successful surgical removal of occult metastases of medullary thyroid carcinoma recurrences with the help of immunoscintigraphy and radioimmunoguidedsurgery, CLIN CANC R, 6(2), 2000, pp. 363-371
Authors:
Eurin, J
Barthelemy, C
Masson, F
Maistre, G
Soualmia, H
Noe, E
Sarfati, E
Eurin, B
Carayon, A
Citation: J. Eurin et al., Release of neuropeptide Y and hemodynamic changes during surgical removal of human pheochromocytomas, REGUL PEPT, 86(1-3), 2000, pp. 95-102
Authors:
Zhang, P
Duchambon, P
Gogusev, J
Nabarra, B
Sarfati, E
Bourdeau, A
Drueke, TB
Citation: P. Zhang et al., Apoptosis in parathyroid hyperplasia of patients with primary or secondaryuremic hyperparathyroidism, KIDNEY INT, 57(2), 2000, pp. 437-445
Authors:
Cattan, P
Halimi, B
Aidan, K
Billotey, C
Tamas, C
Drueke, TB
Sarfati, E
Citation: P. Cattan et al., Reoperation for secondary uremic hyperparathyroidism: Are technical difficulties influenced by initial surgical procedure?, SURGERY, 127(5), 2000, pp. 562-565
Authors:
Brown, SB
Brierley, TT
Palanisamy, N
Salusky, IB
Goodman, W
Brandi, ML
Drueke, TB
Sarfati, E
Urena, P
Chaganti, RSK
Pike, JW
Arnold, A
Citation: Sb. Brown et al., Vitamin D receptor as a candidate tumor-suppressor gene in severe hyperparathyroidism of uremia, J CLIN END, 85(2), 2000, pp. 868-872
Authors:
Cohen, R
Campos, JM
Salaun, C
Massoud, H
Kraimps, HJL
Proye, C
Sarfati, E
Henry, JF
Niccoli-Sire, P
Modigliani, E
Citation: R. Cohen et al., Preoperative calcitonin levels are predictive of tumor size and postoperative calcitonin normalization in medullary thyroid carcinoma, J CLIN END, 85(2), 2000, pp. 919-922
Authors:
Cougard, P
Goudet, P
Peix, JL
Henry, JF
Sarfati, E
Proye, C
Calender, A
Citation: P. Cougard et al., Insulinomas associated with multiple endocrine neoplasia type 1. Report ofa series of 44 cases by "the groupe d'etudes des neoplasies endocriniennesmultiples type 1" (GENEM)., ANN CHIR, 125(2), 2000, pp. 118-123
Authors:
Toubert, ME
Cyna-Gorse, F
Zagdanski, AM
Noel-Wekstein, S
Cattan, P
Billotey, C
Sarfati, E
Rain, JD
Citation: Me. Toubert et al., Cervicomediastinal magnetic resonance imaging in persistent or recurrent papillary thyroid carcinoma: Clinical use and limits, THYROID, 9(6), 1999, pp. 591-597
Authors:
Roussanne, MC
Duchambon, P
Gogusev, J
Sarfati, E
Bourdeau, A
Drueke, TB
Citation: Mc. Roussanne et al., Parathyroid hyperplasia in chronic renal failure: role of calcium, phosphate, and calcitriol, NEPH DIAL T, 14, 1999, pp. 68-69